Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer

PURPOSE: Androgen deprivation therapy may increase diabetes risk. As the benefits of primary androgen deprivation therapy for localized prostate cancer are controversial, and most prostate cancer survivors are of advanced age with comorbidities, it is important to determine if primary androgen depri...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Urol
Prif Awduron: Tsai, Huei-Ting, Keating, Nancy L., Van Den Eeden, Stephen K., Haque, Reina, Cassidy-Bushrow, Andrea E., Yood, Marianne Ulcickas, Smith, Matthew R., Potosky, Arnold L.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4543371/
https://ncbi.nlm.nih.gov/pubmed/25524243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2014.12.027
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg